142 related articles for article (PubMed ID: 25131724)
1. Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia.
Radhakutty A; Shen J; Hooper AJ; Miller SA; Burnett JR; Mah PM; Burt MG; Doogue MP
Diabet Med; 2014 Dec; 31(12):1702-7. PubMed ID: 25131724
[TBL] [Abstract][Full Text] [Related]
2. Extreme diabetic lipaemia associated with a novel lipoprotein lipase gene mutation.
McLean AG; Petersons CJ; Hooper AJ; Burnett JR; Burt MG; Doogue MP
Clin Chim Acta; 2009 Aug; 406(1-2):167-9. PubMed ID: 19447100
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
Chokshi N; Blumenschein SD; Ahmad Z; Garg A
J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
[TBL] [Abstract][Full Text] [Related]
5. LPL gene mutation as the cause of severe hypertriglyceridemia in the course of ketoacidosis in a patient with newly diagnosed type 1 diabetes mellitus.
Nocoń-Bohusz J; Wikiera B; Basiak A; Śmigiel R; Noczyńska A
Pediatr Endocrinol Diabetes Metab; 2016 Feb; 21(2):89-92. PubMed ID: 26901141
[TBL] [Abstract][Full Text] [Related]
6. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
[TBL] [Abstract][Full Text] [Related]
7. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene.
Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S
J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis.
Chang YT; Chang MC; Su TC; Liang PC; Su YN; Kuo CH; Wei SC; Wong JM
J Clin Gastroenterol; 2009 Jul; 43(6):591-6. PubMed ID: 19034041
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Xie SL; Chen TZ; Huang XL; Chen C; Jin R; Huang ZM; Zhou MT
PLoS One; 2015; 10(6):e0129488. PubMed ID: 26079787
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus.
Klannemark M; Suurinkeroinen L; Orho-Melander M; Groop L; Taskinen MR
Diabet Med; 2000 Aug; 17(8):599-605. PubMed ID: 11073182
[TBL] [Abstract][Full Text] [Related]
11. Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain.
Lamiquiz-Moneo I; Blanco-Torrecilla C; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Cenarro A; Civeira F; de Castro-Orós I
Lipids Health Dis; 2016 Apr; 15():82. PubMed ID: 27108409
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men.
Jackson KG; Knapper-Francis JM; Morgan LM; Webb DH; Zampelas A; Williams CM
Clin Sci (Lond); 2003 Oct; 105(4):457-66. PubMed ID: 12812518
[TBL] [Abstract][Full Text] [Related]
13. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency.
Marçais C; Bernard S; Merlin M; Ulhmann M; Mestre B; Rochet-Mingret L; Revol A; Berthezene F; Moulin P
Diabetologia; 2000 Nov; 43(11):1346-52. PubMed ID: 11126401
[TBL] [Abstract][Full Text] [Related]
14. Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
Kassner U; Salewsky B; Wühle-Demuth M; Szijarto IA; Grenkowitz T; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Eur J Hum Genet; 2015 Sep; 23(9):1259-61. PubMed ID: 25585702
[TBL] [Abstract][Full Text] [Related]
15. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic ketoacidosis with severe hypertriglyceridemia and eruptive xanthomata (author's transl)].
Ginies JL; Berthelot J; Limal JM
Arch Fr Pediatr; 1980 Jan; 37(1):55-7. PubMed ID: 6781445
[TBL] [Abstract][Full Text] [Related]
17. Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence.
Chyzhyk V; Kozmic S; Brown AS; Hudgins LC; Starc TJ; Davila AD; Blevins TC; Diffenderfer MR; He L; Geller AS; Rush C; Hegele RA; Schaefer EJ
J Clin Lipidol; 2019; 13(1):89-99. PubMed ID: 30352774
[TBL] [Abstract][Full Text] [Related]
18. The Asn-291-->Ser and Ser-477-->Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia.
Knudsen P; Murtomäki S; Antikainen M; Ehnholm S; Lahdenperä S; Ehnholm C; Taskinen MR
Eur J Clin Invest; 1997 Nov; 27(11):928-35. PubMed ID: 9395789
[TBL] [Abstract][Full Text] [Related]
19. Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes.
Phillips C; Owens D; Collins P; Tomkin GH
Atherosclerosis; 2005 Jul; 181(1):109-14. PubMed ID: 15939061
[TBL] [Abstract][Full Text] [Related]
20. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
